{'fraction_non_alphanumeric': 0.019688269073010665, 'fraction_numerical': 0.019688269073010665, 'mean_word_length': 5.192893401015229, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Analysis of the Value of Combined C-Peptide and Glycosylated Haemoglobin Tests in the Diagnosis of Type 2 Diabetes

Objective: To explore serum C-peptide combined glycosylated hemoglobin value in the diagnosis of type 2 diabetes. Methods: 120 patients with type 2 diabetes admitted to First Affiliated Hospital of Dali University from April 2021 to October 2021 were selected as the experimental group, and 120 healthy subjects during the same period were selected as the control group. Serum C-peptide and HbA1c were detected in both the experimental group and the control group, and relevant data were collected for statistical analysis. Results: Compared with the control group, the HbA1c value in the experimental group was significantly higher and the serum C-peptide level in the experimental group was significantly lower than that in the control group ( P < 0.05). Conclusion: Patients with type 2 diabetes have significantly lower serum C-peptide levels and significantly higher glycosylated haemoglobin levels, compared to healthy subjects. The combined detection of the two indicators can provide reliable reference information for the screening and diagnosis of type 2 diabetes mellitus, and has high value.